Skip Main Navigation
Our Journals
The Lancet Respiratory Medicine is launching in March 2013. Following in the footsteps of its sister journals, the journal will provide high quality content in respiratory medicine and critical care. Please click here for call for papers
A resource for cardiologists providing a collection of cardiology papers, podcasts, and videos from The Lancet journals
The Lancet Diabetes & Endocrinology will launch in August 2013. As well as cutting edge Original Research, the journal will feature timely news and views in diabetes, endocrinology, and metabolism. See: call for papers.
Selected Online First articles from The Lancet journals ahead of print publication.
The Lancet's summary of news and developments across medicine
This Week in Medicine represents a snapshot of important, interesting, and sometimes quirky health-related happenings from around the world reported in the past week or so. This up-to-date content is free to all our users.
Making the most of evaluation

Papers published on The Lancet UK Policy Matters microsite raise concerns about the quality of past evaluations commissioned directly or indirectly by the Department of Health. Read the papers and accompanying blog post to find out more.

About UK Policy Matters

UK Policy Matters is a Lancet-based project which explores how UK policy changes affect health. On our microsite you will be able to access evidence-based summaries of different policies and tell us your experiences of how changes in policy have affected health.

How can you help?

If you have evidence of how policy has affected health or health care, we would like to hear from you. We are interested in all forms of evidence, including brief summaries of evidence from academics; and information from the public, managers, and healthcare workers about changes in services and their impact (individual experiences are welcomed).

See the Submit your evidence section of the site to share your experiences and submit your evidence.

Most read in The Lancet journals in January 2013
1. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis
Article (2012) The Lancet Infectious Diseases 12 (1), pp. 36-44
2. Return to Alma-Ata
Comment (2008) The Lancet 372 (9642), pp. 865-866
3. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK
Article (2013) The Lancet 381 (9861), pp. 133-141
4. High-risk drug practices tighten grip on London gay scene
World Report (2013) The Lancet 381 (9861), pp. 101-102
5. GBD 2010: understanding disease, injury, and risk
Comment (2012) The Lancet 380 (9859), pp. 2053-2054
Most cited in The Lancet since 1996
1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Research (1998) Lancet 352 (9131), pp. 837-853
2. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomised placebo-controlled trial
Research (2002) Lancet 360 (9326), pp. 7-22
3. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
Research (1998) Lancet 351 (9118), pp. 1755-1762
4. Peginterferon alfa-2b plus ribavirin compared with interferonalfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
Research (2001) Lancet 358 (9286), pp. 958-965
5. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
Research (1996) Lancet 348 (9038), pp. 1329-1339